Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Corrado Cilio


Default user image.

Dissecting the role of micro-RNAs in diabetes


  • Caroline Bolmeson

Summary, in English

The role of miRNAs in pancreatic islets and β-cell function and in the development of diabetes in human and rodents have been investigated in this thesis. Dicer1 was specifically deleted in vivo in pancreatic β-cells under the RIP-promoter in mice. The results show that disruption of miRNAprocessing in mouse pancreatic β-cells, while compatible with β-cell development, leads to defective insulin-secreting function and progressive overt diabetes mellitus. The miRNA profiles were investigated in the non-obese type 2 diabetes rat model, Goto-Kakizaki (GK), and in healthy Wistar controls, revealing that specific miRNAs in GK rat pancreatic islets display aberrant expression when islets were challenged with glucose. One of these miRNAs, miR-335, was experimentally shown to target Syntaxin-binding protein-1 (Stxbp1), a protein important for insulin exocytosis. In the non-obese diabetic mouse (NOD), a well-established mouse model for type 1 diabetes, the possibility of miRNA-involvment in the apoptosis-resistance in thymocytes in these mice were investigated. Apoptosis-resistant auto-reactive thymocytes may give rise to the autoimmune diabetes observed in the NOD mouse. The results showed that miR-34a/b/c is defectively upregulated in NOD thymocytes compared to B6 mouse control thymocytes. Additionally, the genes of

this miRNA-family resides in diabetes susceptibility loci. Sequencing mir-34a revealed a deletion in the pregene segment within a basepair from a putative p53-binding site. Finally, it has been observed in other studies (1, 2) that the well-known islet miRNA, miR-375, is abundantly expressed in islets. This was confirmed and it was also demonstrated that miR-375 is positively correlated to insulin biosynthesis in healthy human islets (HbA1c < 6.1). The same interesting pattern of expression was observed for miR-122, 127-3p and miR-184. Additionally, miR-127-3p and miR-184 were negatively correlated to glucose-stimulated insulin secretion (GSIS). All correlation between these miRNAs and the insulin mRNA and insulin secretion was lost in human islets from glucose intolerant donors with (HbA1c ≥ 6.1). To conclude, miRNAs have been demonstrated to be essential for β-cells and islet function in mouse, rat and human. From the results of this thesis it can be suggested that a disturbed miRNA network in the ieither a cause or a consequence of events giving rise to pathogenicity in the form of diabetes.


  • Create Health
  • Evolutionary ecology
  • Cellular Autoimmunity Unit-lup-obsolete
  • EXODIAB: Excellence in Diabetes Research in Sweden

Publishing year





Lund University Faculty of Medicine Doctoral Dissertation Series



Document type



Department of Clinical Sciences, Lund University


  • Endocrinology and Diabetes


  • Type 1 diabetes
  • Type 2 diabetes
  • micro-RNA
  • Dicer
  • beta-cell function
  • insulin secretion
  • glucose
  • NOD mouse
  • Goto-Kakizaki rat
  • human islets
  • thymocytes
  • apoptosis



Research group

  • Cellular Autoimmunity Unit-lup-obsolete


  • Corrado Cilio
  • Lena Eliasson


  • ISSN: 1652-8220
  • ISBN: 978-91-86871-35-2

Defence date

21 October 2011

Defence time


Defence place

Jubileumsaulan, entrance 59, SUS Malmö


  • Flemming Pociot (Professor)